1. Cannabis stocks surged on reports of potential reclassification by Trump. 2. Moving cannabis to Schedule III may ease restrictions and boost R&D. 3. Major gains seen in multiple cannabis companies, including Aurora Cannabis. 4. Any changes require a lengthy regulatory process and congressional action. 5. The rally reflects optimism after years of industry decline.